e-learning
resources
London 2016
Sunday, 04.09.2016
Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Severe pneumonia mortality in pediatric patients is associated with downregulation of Toll-like receptors 2 and 4 on monocytes
Kostiantyn Dmytriiev (Vinnitsya, Ukraine), Kostiantyn Dmytriiev, Dmytro Dmytriiev, Kateryna Dmytriieva, Olexandr Katilov, Olexandr Nazarchuk, Yuriy Otkalenko
Source:
International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Session:
Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Session type:
Thematic Poster
Number:
1304
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kostiantyn Dmytriiev (Vinnitsya, Ukraine), Kostiantyn Dmytriiev, Dmytro Dmytriiev, Kateryna Dmytriieva, Olexandr Katilov, Olexandr Nazarchuk, Yuriy Otkalenko. Severe pneumonia mortality in pediatric patients is associated with downregulation of Toll-like receptors 2 and 4 on monocytes. Eur Respir J 2016; 48: Suppl. 60, 1304
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
From pulmonary gas exchange to the interpretation of arterial blood gases
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Cytokine and chemokine profile in a cohort of children with community acquired pneumonia
Source: International Congress 2016 – Paediatric respiratory infection
Year: 2016
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
30 day mortality and eosinopenia in patients with pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Risk factors for mortality in severe pneumonia patients followed in ICU
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Risk factors for pleural complications in children with community acquired pneumonia
Source: Annual Congress 2013 –The burden of respiratory infections in children
Year: 2013
Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Decreased toll-like receptor 4 expression in induced sputum associated with increased frequency of acute exacerbation in COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Toll-like receptor 3 expression in fatal asthma
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
YKL-40 and CCL18 predict mortality in patients hospitalised with community-acquired pneumonia; an observational analysis
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Increased expression of toll-like receptor 2 (TLR2) in the small airways of fatal asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 285s
Year: 2007
Cardiac autonomic alterations impact early and late outcomes in patients with community-acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Soluble form of CD95 (Fas/Apo-1) in patients with community-acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 320s
Year: 2004
Exploring the immune status of sepsis patients through Tim-3 expressed on monocytes and IL-12
Source: International Congress 2014 – ICU outcomes, sepsis and infections
Year: 2014
Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Pneumonia severity index (PSI) at young patients and toll-like receptor 4 (TLR4) polymorphism interconnections: new diagnostic approach
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept